Page last updated: 2024-09-04

levofloxacin and camostat

levofloxacin has been researched along with camostat in 1 studies

Compound Research Comparison

Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010)
(levofloxacin)
Studies
(camostat)
Trials
(camostat)
Recent Studies (post-2010) (camostat)
4,3465812,2093371493

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)camostat (IC50)
Transmembrane protease serine 2Homo sapiens (human)0.018
ProthrombinHomo sapiens (human)0.399
Serine protease hepsinHomo sapiens (human)0.0235
Trypsin-1Homo sapiens (human)0.0035
Trypsin-2Homo sapiens (human)0.0035
Procathepsin LHomo sapiens (human)0.018
FurinHomo sapiens (human)0.018
Trypsin-3Homo sapiens (human)0.0035
Transmembrane protease serine 6Homo sapiens (human)0.018
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA1

Other Studies

1 other study(ies) available for levofloxacin and camostat

ArticleYear
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013